Sale!

WAS Gene Thrombocytopenia X-Linked Intermittent Genetic Test

Name: WAS Gene Thrombocytopenia X-Linked Intermittent Genetic Test
SKU: TEST-3962
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “WAS Gene Thrombocytopenia X-Linked Intermittent Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the WAS gene. This gene plays a crucial role in the immune system and cell signaling. Mutations in the WAS gene are associated with Wiskott-Aldrich Syndrome, a rare X-linked recessive disorder characterized by eczema, thrombocytopenia (low platelet count), immune deficiency, and an increased risk of autoimmune diseases and cancers. The test specifically targets individuals suspected of having intermittent expressions of the syndrome, providing crucial information for accurate diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient’s genetic makeup, contributing to targeted treatment strategies and improved patient care.

Description

WAS Gene Thrombocytopenia X-linked intermittent Genetic Test

At DNA Labs UAE, we offer the WAS Gene Thrombocytopenia X-linked intermittent Genetic Test at a cost of AED 4400.0.

Test Name: WAS Gene Thrombocytopenia X-linked intermittent Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for WAS Gene Thrombocytopenia, X-linked, intermittent NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WAS Gene Thrombocytopenia, X-linked, intermittent NGS Genetic DNA Test gene WAS

Test Details:

WAS Gene Thrombocytopenia, X-linked, intermittent (WAS-XLT) is a rare genetic disorder that primarily affects males. It is caused by mutations in the Wiskott-Aldrich syndrome (WAS) gene, which is located on the X chromosome. The WAS gene provides instructions for producing a protein called WASp, which plays a crucial role in the functioning of immune cells and platelets. Mutations in this gene result in a deficiency or dysfunction of the WASp protein, leading to the symptoms associated with WAS-XLT.

The main features of WAS-XLT include intermittent episodes of thrombocytopenia (low platelet count), eczema (skin rash), and recurrent infections. Individuals with this condition may also experience easy bruising, bloody nose, and prolonged bleeding after injury or surgery. In severe cases, they may develop autoimmune disorders, malignancies, or have an increased risk of bleeding complications.

Next-generation sequencing (NGS) genetic testing is a diagnostic tool used to identify mutations in the WAS gene. This test involves analyzing the DNA sequence of the gene to detect any alterations or abnormalities. NGS allows for the simultaneous analysis of multiple genes, providing a more comprehensive assessment of genetic variants associated with WAS-XLT.

The NGS genetic test for WAS-XLT can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It is typically performed on individuals suspected to have WAS-XLT based on their clinical symptoms and family history.

It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of genetic testing for WAS-XLT. They can provide guidance on the appropriate testing approach and help interpret the results in the context of an individual’s specific situation.

Test Name	WAS Gene Thrombocytopenia X-linked intermittent Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for WAS Gene Thrombocytopenia, X-linked, intermittent NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WAS Gene Thrombocytopenia, X-linked, intermittent NGS Genetic DNA Test gene WAS
Test Details	WAS Gene Thrombocytopenia, X-linked, intermittent (WAS-XLT) is a rare genetic disorder that primarily affects males. It is caused by mutations in the Wiskott-Aldrich syndrome (WAS) gene, which is located on the X chromosome. The WAS gene provides instructions for producing a protein called WASp, which plays a crucial role in the functioning of immune cells and platelets. Mutations in this gene result in a deficiency or dysfunction of the WASp protein, leading to the symptoms associated with WAS-XLT. The main features of WAS-XLT include intermittent episodes of thrombocytopenia (low platelet count), eczema (skin rash), and recurrent infections. Individuals with this condition may also experience easy bruising, bloody nose, and prolonged bleeding after injury or surgery. In severe cases, they may develop autoimmune disorders, malignancies, or have an increased risk of bleeding complications. Next-generation sequencing (NGS) genetic testing is a diagnostic tool used to identify mutations in the WAS gene. This test involves analyzing the DNA sequence of the gene to detect any alterations or abnormalities. NGS allows for the simultaneous analysis of multiple genes, providing a more comprehensive assessment of genetic variants associated with WAS-XLT. The NGS genetic test for WAS-XLT can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It is typically performed on individuals suspected to have WAS-XLT based on their clinical symptoms and family history. It is important to consult with a healthcare professional or a genetic counselor to understand the benefits, limitations, and implications of genetic testing for WAS-XLT. They can provide guidance on the appropriate testing approach and help interpret the results in the context of an individual’s specific situation.